HealthPro BioVentures

Healthcare & Life Sciences Investment Banking

HealthPro BioVentures LLC provides strategic advisory and investment banking services to emerging companies in the healthcare and life sciences sectors. Today’s challenging healthcare market is our sole focusOur highly experienced staff is comprised of financial professionals from within both the healthcare investment banking and life sciences communities. HealthPro is prepared to play a vital role in helping you secure the financial support and strategic partners that you need to reach your corporate objectives and to maximize your value. 

Filtering by Author: Martin Kratchman

Jorge Leon, PhD

Diagnostics

Jorge Leon is an internationally recognized expert and pioneer in the field of development and commercialization of clinical molecular diagnostics. Dr. Leon has a PhD in Cellular and Molecular Biology from NYU and completed his post doctoral studies at the German Cancer Research Center in Heidelberg, Germany and Columbia University in NYC.

Read More

Ira Herman, PhD

Regenerative Medicine and Wound Healing

Dr. Ira M. Herman is a tenured professor and director of the Center for Innovations in Wound Healing Research at the Tufts University School of Medicine. Dr. Herman holds appointments in the departments of physiology, anatomy & cellular biology, ophthalmology and biomedical engineering. Professor Herman is a founding member and director emeritus of the Integrated Studies Program at the Sackler School of Graduate Biomedical Sciences at Tufts University School of Medicine and is a recipient of the Distinguished Faculty Award.

Read More

Zahed Subhan, PhD, JD, MBA

Pharmacology

Presently Chief Executive Officer and co-founder of Marillion Pharmaceuticals Inc, Dr. Subhan has 25 years experience in the pharmaceutical and biotechnology industries spanning roles in research, clinical development, sales, marketing and business development, including managerial positions with Sanofi-Aventis, GlaxoSmithKline, Merck, the Dupont-Merck Pharmaceutical Company (now part of Bristol-Myers Squibb), Gemini Genomics (now Sequenom, Inc) and Locus Pharmaceuticals.

Read More

Gurinder Shahi, MD, PhD, MPH

Vaccines & Virology

Chief Technologist and Chairman of Scientific Board, Industrial Biotechnology Corporation; Executive Director, Global BioBusiness Initiative; Chairman, BioEnterprise Asia

Dr. Shahi is a physician with a PhD in molecular biochemistry from the National University of Singapore and a Masters degree in Public Health (international health policy and management) from Harvard University. He is a leading expert on technology innovation and change management in healthcare and BioBusiness.

Read More